Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cathflo for Pediatric Intra-abdominal Abscess
NCT01576679Phase 3Terminated
- Sponsor
- SickKids
- Start
- Mar 2012
- Primary completion
- May 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intra-abdominal abscess (IAA) comparing tPA with Placebo (2 arms). Primary endpoint: Length of time the drain remains insitu at 2 weeks. Started Mar 2012; status: terminated.
02
Drugs
tissue-plasminogen activator
03
Conditions
intra-abdominal abscess (IAA)
Beyond the preview
Go deeper on NCT01576679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576679.